Innoviva, Inc.
INVANasdaqCIK 1080014HealthcareFiscal year ends Dec 31
Reports and events: 473 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0516:26 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-335235 |
| 2026-08-0516:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335192 |
| 2026-05-1816:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-228958 |
| 2026-05-0616:29 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-209110 |
| 2026-05-0616:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-209044 |
| 2026-05-0416:59 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-204243 |
| 2026-03-2716:01 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-128939 |
| 2026-03-2416:51 ET | DEF 14A | Proxy statementPeriod 2026-03-24 | 0001140361-26-010912 |
| 2026-02-2516:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071974 |
| 2026-02-2516:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-071776 |
| 2025-11-0516:28 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-267040 |
| 2025-11-0516:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107014 |
| 2025-08-0616:27 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104126 |
| 2025-08-0616:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074730 |
| 2025-05-2116:15 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-051614 |
| 2025-05-0716:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065765 |
| 2025-05-0716:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-045556 |
| 2025-04-0816:05 ET | DEF 14A | Proxy statementPeriod 2025-05-19 | 0001193125-25-075695 |
| 2025-03-2416:15 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-043848 |
| 2025-03-1721:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-25-000427 |
| 2025-03-0721:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-25-000411 |
| 2025-02-2616:48 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027864 |
| 2025-02-2616:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-017461 |
| 2024-11-0616:25 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122375 |
| 2024-11-0616:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-114800 |
| 2024-07-3116:47 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-088661 |
| 2024-07-3116:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-084357 |
| 2024-06-2016:30 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-073416 |
| 2024-05-1309:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-060280 |
| 2024-05-0816:46 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055832 |
| 2024-05-0816:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-058747 |
| 2024-04-3018:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-123033 |
| 2024-04-2917:25 ET | DEF 14A | Proxy statementPeriod 2024-06-17 | 0001193125-24-122923 |
| 2024-03-2216:42 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0000950170-24-035419 |
| 2024-03-0518:14 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0000950170-24-025088 |
| 2024-02-2917:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023237 |
| 2024-02-2916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-029378 |
| 2023-11-0608:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-114509 |
| 2023-11-0116:44 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-057530 |
| 2023-11-0116:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-113410 |
| 2023-08-2517:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-095406 |
| 2023-08-0716:42 ET | 8-K | 3.01 Delisting notice | 0001104659-23-088390 |
| 2023-08-0217:02 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-037296 |
| 2023-08-0216:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-086806 |
| 2023-07-1108:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-079823 |
| 2023-05-2417:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-064192 |
| 2023-05-2418:07 ET | 8-K | 5.07 Shareholder vote results | 0001104659-23-063704 |
| 2023-05-1517:05 ET | SC 13D/A | Ownership report, active investor, amended | 0000899140-23-000652 |
| 2023-05-0917:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-057825 |
| 2023-05-0917:05 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019835 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:26 ET. Listed shows no prices and gives no investment advice.